Biolase Inc (NASDAQ CAPITAL MARKET:BIOL)

Expected performance: Start your 30-days free trial
About the company

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

CEO

Todd Norbe

Exchange

NASDAQ CAPITAL MARKET

Website

www.biolase.com

$26.00M

Total Revenue

135

Employees

$49.59M

Market Capitalization

-1.33

Price/Earning ratio

Stock price

Gross Margin (%)

Total gross margin

$8M

Operating Margin (%)

Total operating margin

$-19M

Net Margin (%)

Total net margin

$-35M

Dividend Yield (%)

Dividend per share

$0

90-days Stock Price Forecast (%)

PREDICT MONTHLY

$29.9 / Month

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed monthly
  • Cancel anytime

OPTIMIZE YEARLY

$479.9 / Year

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed yearly
  • Cancel anytime

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (%)
DENTSPLY Sirona Inc XRAY 14462.76 3495.00 2.93 84.67 4.98
Envista Holdings Corp NVST 7237.44 2444.00 1.85 59.83 5.00
Smiledirectclub Inc SDC 2725.16 660.00 12.39 -10.23 -11.83
Biolase Inc BIOL 49.59 26.00 2.59 -1.33 -136.46
Biomerica Inc. BMRA 45.00 9.00 4.36 -8.15 -61.56

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Here’s Our Rant About BIOLASE Inc. (BIOL)

2d ago, source: newsheater

BIOLASE Inc. (NASDAQ:BIOL) went up by 4.58% from its latest closing price compared to the recent 1-year high of $1.51. The company’s stock price has collected -2.31% of loss in the last five trading ...

How Will BIOLASE Inc. (NASDAQ: BIOL) Perform In Months To Come?

3d ago, source: marketingsentinel

BIOLASE Inc. (NASDAQ:BIOL) has a beta value of 1.46 and has seen 1.66 million shares traded in the last trading session. The company, currently valued at $87.15M, closed the last trade at $0.56 per ...

Buy or Sell BIOLASE Inc. (BIOL) Stock Now | Don’t Try to Be a Top Gun

9d ago, source: newsheater

BIOLASE Inc. (NASDAQ:BIOL) went up by 5.26% from its latest closing price compared to the recent 1-year high of $1.51. The ...

Biolase Inc.

2d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

What Did We Learn From BIOLASE Inc. (NASDAQ: BIOL) Insider Trading?

4d ago, source: stocksregister

BIOLASE Inc. (NASDAQ:BIOL) traded at $0.58 at close of the session on Monday, July 26, made a downward move of -2.12% on its previous day’s price. Looking at the stock we see that its previous close ...

BIOLASE Inc. (BIOL) Quarterly Performance is -18.54%: Here is the Surprise Factor

9d ago, source: investchronicle

At the end of the latest market close, BIOLASE Inc. (BIOL) was valued at $0.60. In that particular session, Stock kicked-off at the price of $0.575 while reaching the peak value of $0.628 and lowest ...

Following Its 52-Week Low, BIOLASE Inc. (NASDAQ: BIOL)’S Share Price Rose 59.68% And Its YTD Numbers Rise 44.13%

9d ago, source: marketingsentinel

During the recent session, BIOLASE Inc. (NASDAQ:BIOL)’s traded shares were 0.96 million, with the beta value of the company hitting 1.46. At the last check today, the stock’s price was $0.62, ...

Your Portfolio

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.